Skip navigation

GO Term kinase activity

1–50 of 398 results.
  Phenotype Chemical Co-Mentioned Terms Interaction Organisms Anatomy Inference Network References
1. protein kinase C activity 1,2-didecanoylglycerol Calcium [1,2-didecanoylglycerol co-treated with Calcium] results in increased protein kinase C activity 1: Rodentia Brain   1
2. creatine kinase activity 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin Lipopolysaccharides 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin inhibits the reaction [Lipopolysaccharides results in increased creatine kinase activity] 1: Rattus norvegicus Plasma   1
3. creatine kinase activity 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin Lipopolysaccharides | Quercetin Quercetin inhibits the reaction [17-(dimethylaminoethylamino)-17-demethoxygeldanamycin inhibits the reaction [Lipopolysaccharides results in increased creatine kinase activity]] 1: Rattus norvegicus Plasma   1
4. MAP kinase activity 2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole Tretinoin 2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole inhibits the reaction [Tretinoin results in increased MAP kinase activity] 1: Mus musculus Blastocyst | Cell Line
4 genes: MAPK1 | MAPK11 | MAPK14 | MAPK3
1
5. creatine kinase activity 3-(2,2,2-trimethylhydrazine)propionate response to activity [3-(2,2,2-trimethylhydrazine)propionate affects response to activity] which affects creatine kinase activity 1: Rattus norvegicus Plasma   1
6. creatine kinase activity 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity 1: Rattus norvegicus Cerebral Cortex | Cytoplasm   1
7. creatine kinase activity 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity 1: Rattus norvegicus Cerebral Cortex | Mitochondria   1
8. creatine kinase activity 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity 1: Rattus norvegicus Cerebellum | Cytoplasm   1
9. creatine kinase activity 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity 1: Rattus norvegicus Cerebellum | Mitochondria   1
10. creatine kinase activity 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one phosphocreatine catabolic process [3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity] which results in decreased phosphocreatine catabolic process 1: Rattus norvegicus Cerebral Cortex | Cytoplasm   1
11. creatine kinase activity 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one phosphocreatine catabolic process [3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity] which results in decreased phosphocreatine catabolic process 1: Rattus norvegicus Cerebral Cortex | Mitochondria   1
12. creatine kinase activity 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one phosphocreatine catabolic process [3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity] which results in decreased phosphocreatine catabolic process 1: Rattus norvegicus Cerebellum | Cytoplasm   1
13. creatine kinase activity 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one phosphocreatine catabolic process [3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity] which results in decreased phosphocreatine catabolic process 1: Rattus norvegicus Cerebellum | Mitochondria   1
14. creatine kinase activity 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one Glutathione Glutathione inhibits the reaction [3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity] 1: Rattus norvegicus Cerebral Cortex | Cytoplasm   1
15. creatine kinase activity 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one Glutathione Glutathione inhibits the reaction [3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity] 1: Rattus norvegicus Cerebral Cortex | Mitochondria   1
16. creatine kinase activity 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one Glutathione Glutathione inhibits the reaction [3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity] 1: Rattus norvegicus Cerebellum | Cytoplasm   1
17. creatine kinase activity 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one Glutathione Glutathione inhibits the reaction [3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity] 1: Rattus norvegicus Cerebellum | Mitochondria   1
18. creatine kinase activity 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one Glutathione | phosphocreatine catabolic process Glutathione inhibits the reaction [[3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity] which results in decreased phosphocreatine catabolic process] 1: Rattus norvegicus Cerebral Cortex | Cytoplasm   1
19. creatine kinase activity 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one Glutathione | phosphocreatine catabolic process Glutathione inhibits the reaction [[3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity] which results in decreased phosphocreatine catabolic process] 1: Rattus norvegicus Cerebral Cortex | Mitochondria   1
20. creatine kinase activity 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one Glutathione | phosphocreatine catabolic process Glutathione inhibits the reaction [[3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity] which results in decreased phosphocreatine catabolic process] 1: Rattus norvegicus Cerebellum | Cytoplasm   1
21. creatine kinase activity 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one Glutathione | phosphocreatine catabolic process Glutathione inhibits the reaction [[3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity] which results in decreased phosphocreatine catabolic process] 1: Rattus norvegicus Cerebellum | Mitochondria   1
22. MAP kinase activity 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline affects MAP kinase activity 1: Homo sapiens Mouth | Cell Line, Tumor
2 genes: MAPK1 | MAPK3
1
23. hexokinase activity 4-hydroxyphenylethanol Streptozocin 4-hydroxyphenylethanol inhibits the reaction [Streptozocin results in decreased hexokinase activity] 1: Rattus norvegicus Liver   1
24. hexokinase activity 4-hydroxyphenylethanol Streptozocin 4-hydroxyphenylethanol inhibits the reaction [Streptozocin results in decreased hexokinase activity] 1: Rattus norvegicus Kidney   1
25. AMP-activated protein kinase activity (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine A 769662 (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [A 769662 results in increased AMP-activated protein kinase activity] 1: Mus musculus Heart
5 genes: PRKAA1 | PRKAA2 | PRKAB2 | PRKAG1 | PRKAG2
1
26. AMP-activated protein kinase activity (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine Metformin (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [Metformin results in increased AMP-activated protein kinase activity] 1: Mus musculus Heart
5 genes: PRKAA1 | PRKAA2 | PRKAB2 | PRKAG1 | PRKAG2
1
27. AMP-activated protein kinase activity (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine A 769662 | Lipopolysaccharides (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [[A 769662 co-treated with Lipopolysaccharides] results in increased AMP-activated protein kinase activity] 1: Mus musculus Heart
5 genes: PRKAA1 | PRKAA2 | PRKAB2 | PRKAG1 | PRKAG2
1
28. AMP-activated protein kinase activity (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine positive regulation of peptidyl-threonine phosphorylation [(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine results in decreased positive regulation of peptidyl-threonine phosphorylation] which results in decreased AMP-activated protein kinase activity 1: Homo sapiens Lung | Cell Line, Tumor
5 genes: PRKAA1 | PRKAA2 | PRKAB2 | PRKAG1 | PRKAG2
1
29. MAP kinase activity 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid Vitamin A 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Vitamin A results in increased MAP kinase activity] 1: Rattus norvegicus Sertoli Cells
4 genes: MAPK1 | MAPK3 | MAPK8 | MAPK9
1
30. AMP-activated protein kinase activity 7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid 7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid results in increased AMP-activated protein kinase activity 1: Mus musculus Hepatocytes | Cells, Cultured   1
31. AMP-activated protein kinase activity 7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid ATP2A2 [7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid results in increased AMP-activated protein kinase activity] which results in increased expression of ATP2A2 mRNA 1: Mus musculus Hepatocytes | Cells, Cultured   1
32. AMP-activated protein kinase activity 7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid ATP2A2 [7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid results in increased AMP-activated protein kinase activity] which results in increased expression of ATP2A2 protein 1: Mus musculus Hepatocytes | Cells, Cultured   1
33. AMP-activated protein kinase activity 7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid HIF1A [7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid results in increased AMP-activated protein kinase activity] which results in increased expression of HIF1A protein 1: Mus musculus Hepatocytes | Cells, Cultured   1
34. AMP-activated protein kinase activity 7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid Palmitic Acid [7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid results in increased AMP-activated protein kinase activity] which results in decreased susceptibility to Palmitic Acid 1: Mus musculus Hepatocytes | Cells, Cultured   1
35. AMP-activated protein kinase activity 7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid Palmitic Acid | positive regulation of sequestering of triglyceride [7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid results in increased AMP-activated protein kinase activity] inhibits the reaction [Palmitic Acid results in increased positive regulation of sequestering of triglyceride] 1: Mus musculus Hepatocytes | Cells, Cultured   1
36. AMP-activated protein kinase activity 7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid Palmitic Acid | positive regulation of IRE1-mediated unfolded protein response [7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid results in increased AMP-activated protein kinase activity] inhibits the reaction [Palmitic Acid results in increased positive regulation of IRE1-mediated unfolded protein response] 1: Mus musculus Hepatocytes | Cells, Cultured   1
37. AMP-activated protein kinase activity 7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid Palmitic Acid | SREBF1 [7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid results in increased AMP-activated protein kinase activity] inhibits the reaction [Palmitic Acid results in increased expression of SREBF1 protein modified form] 1: Mus musculus Hepatocytes | Cells, Cultured   1
38. AMP-activated protein kinase activity 7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid FASN | Palmitic Acid [7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid results in increased AMP-activated protein kinase activity] inhibits the reaction [Palmitic Acid results in increased expression of FASN protein] 1: Mus musculus Hepatocytes | Cells, Cultured   1
39. AMP-activated protein kinase activity 7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid Palmitic Acid | SCD1 [7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid results in increased AMP-activated protein kinase activity] inhibits the reaction [Palmitic Acid results in increased expression of SCD1 protein] 1: Mus musculus Hepatocytes | Cells, Cultured   1
40. AMP-activated protein kinase activity 7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid GPAM | Palmitic Acid [7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid results in increased AMP-activated protein kinase activity] inhibits the reaction [Palmitic Acid results in increased expression of GPAM mRNA] 1: Mus musculus Hepatocytes | Cells, Cultured   1
41. AMP-activated protein kinase activity 7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid ME1 | Palmitic Acid [7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid results in increased AMP-activated protein kinase activity] inhibits the reaction [Palmitic Acid results in increased expression of ME1 mRNA] 1: Mus musculus Hepatocytes | Cells, Cultured   1
42. AMP-activated protein kinase activity 7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid DDIT3 | Palmitic Acid [7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid results in increased AMP-activated protein kinase activity] inhibits the reaction [Palmitic Acid results in increased expression of DDIT3 protein] 1: Mus musculus Hepatocytes | Cells, Cultured   1
43. AMP-activated protein kinase activity 7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid Palmitic Acid | XBP1 [7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid results in increased AMP-activated protein kinase activity] inhibits the reaction [Palmitic Acid results in increased expression of XBP1 mRNA alternative form] 1: Mus musculus Hepatocytes | Cells, Cultured   1
44. AMP-activated protein kinase activity 7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid ERN1 | Palmitic Acid [7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid results in increased AMP-activated protein kinase activity] inhibits the reaction [Palmitic Acid results in increased phosphorylation of ERN1 protein] 1: Mus musculus Hepatocytes | Cells, Cultured   1
45. AMP-activated protein kinase activity 7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid EIF2S1 | Palmitic Acid [7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid results in increased AMP-activated protein kinase activity] inhibits the reaction [Palmitic Acid results in increased phosphorylation of EIF2S1 protein] 1: Mus musculus Hepatocytes | Cells, Cultured   1
46. AMP-activated protein kinase activity 7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid Dietary Fats 7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid inhibits the reaction [Dietary Fats results in decreased AMP-activated protein kinase activity] 1: Mus musculus Liver   1
47. creatine kinase activity 7-hydroxycoumarin Isoproterenol 7-hydroxycoumarin inhibits the reaction [Isoproterenol results in increased creatine kinase activity] 1: Rattus norvegicus Serum   1
48. AMP-activated protein kinase activity A 769662 A 769662 results in increased AMP-activated protein kinase activity 1: Mus musculus Heart   1
49. AMP-activated protein kinase activity A 769662 Lipopolysaccharides [A 769662 co-treated with Lipopolysaccharides] results in increased AMP-activated protein kinase activity 1: Mus musculus Heart   1
50. AMP-activated protein kinase activity A 769662 (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [A 769662 results in increased AMP-activated protein kinase activity] 1: Mus musculus Heart   1
1–50 of 398 results.